STRATA Skin Net Worth
STRATA Skin Net Worth Breakdown | SSKN |
STRATA Skin Net Worth Analysis
STRATA Skin's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including STRATA Skin's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of STRATA Skin's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform STRATA Skin's net worth analysis. One common approach is to calculate STRATA Skin's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares STRATA Skin's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing STRATA Skin's net worth. This approach calculates the present value of STRATA Skin's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of STRATA Skin's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate STRATA Skin's net worth. This involves comparing STRATA Skin's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into STRATA Skin's net worth relative to its peers.
To determine if STRATA Skin is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STRATA Skin's net worth research are outlined below:
| STRATA Skin Sciences generated a negative expected return over the last 90 days | |
| STRATA Skin Sciences has high historical volatility and very poor performance | |
| STRATA Skin Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 33.56 M. Net Loss for the year was (10.09 M) with profit before overhead, payroll, taxes, and interest of 19.65 M. | |
| STRATA Skin Sciences has a frail financial position based on the latest SEC disclosures | |
| About 64.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Benign Growth For STRATA Skin Sciences, Inc. Underpins Its Share Price |
STRATA Skin uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STRATA Skin Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STRATA Skin's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know STRATA Skin's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as STRATA Skin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STRATA Skin Sciences backward and forwards among themselves. STRATA Skin's institutional investor refers to the entity that pools money to purchase STRATA Skin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Mccormack Advisors International | 2025-03-31 | 300 | Financial Perspectives Inc | 2025-03-31 | 101 | Jpmorgan Chase & Co | 2025-03-31 | 46.0 | Bank Of America Corp | 2025-03-31 | 21.0 | Hanson Mcclain Inc | 2025-03-31 | 5.0 | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 1.0 | Acadian Asset Management Llc | 2024-12-31 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Pnc Financial Services Group Inc | 2024-12-31 | 0.0 | 22nw, Lp | 2025-03-31 | 537 K | Nantahala Capital Management, Llc | 2025-03-31 | 403.9 K |
Follow STRATA Skin's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.72 M.Project STRATA Skin's profitablity
The company has Profit Margin (PM) of (0.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.3) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.3.When accessing STRATA Skin's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures STRATA Skin's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STRATA Skin's profitability and make more informed investment decisions.
Evaluate STRATA Skin's management efficiency
STRATA Skin Sciences has return on total asset (ROA) of (0.076) % which means that it has lost $0.076 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5123) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. At this time, STRATA Skin's Total Current Assets are very stable compared to the past year. As of the 6th of July 2025, Non Currrent Assets Other is likely to grow to about 298.7 K, while Total Assets are likely to drop about 30.5 M.Understanding the management dynamics of STRATA Skin Sciences allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Enterprise Value Revenue 0.5831 | Revenue | Quarterly Revenue Growth 0.009 | Revenue Per Share 8.461 | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STRATA Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on STRATA Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STRATA Skin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
STRATA Skin time-series forecasting models is one of many STRATA Skin's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary STRATA Skin's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
STRATA Skin Earnings per Share Projection vs Actual
STRATA Skin Corporate Management
| Shmuel Gov | Chief Officer | Profile | |
| John Gillings | Principal Officer | Profile | |
| Robert Moccia | CEO Pres | Profile | |
| William MBA | Ex Chairman | Profile | |
| Michael Goodman | Head Sales | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.27) | Revenue Per Share 8.461 | Quarterly Revenue Growth 0.009 | Return On Assets (0.08) | Return On Equity |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.